On Friday, WhiteWave Foods Co (NYSE:WWAV)’s shares inclined 0.24% to $46.82.
WhiteWave Foods Co (WWAV) declared that chairman and chief executive officer, Gregg Engles, executive vice president and chief financial officer, Kelly Haecker, and president of Europe foods and beverages, Bernard Deryckere will present to the investment community at the dbAccess Global Consumer Conference on Wednesday, June 10, 2015 at 8:30 a.m. Central European Summer Time (2:30 a.m. Eastern Daylight Time) in Paris, France.
The WhiteWave Foods Company, a consumer packaged food and beverage company, manufactures, markets, distributes, and sells branded plant-based foods and beverages, salads, fruits and vegetables, coffee creamers and beverages, and dairy products and organic produce in North America and Europe. It operates in three segments: Americas Foods & Beverages, Americas Fresh Foods, and Europe Foods & Beverages.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM)’s shares dropped -1.38% to $2.86.
Actinium Pharmaceuticals Inc (ATNM) declared that it reached subscription agreements with certain investors to sell about $5 million of its common stock in a registered direct offering. Under the terms of the subscription agreements, the Company will issue an aggregate of 1,923,078 shares of the Company’s common stock at a purchase price of $2.60 per share. The offering is predictable to close on or about June 10, 2015, subject to the satisfaction of customary closing conditions. This financing was led by investor Dr. Phillip Frost.
Actinium anticipates using the net proceeds for general corporate purposes, counting capital expenditures, the advancement of our product candidates in clinical trials, such as Iomab™-B and Actimab-A, preclinical trials, to support licensing activities, and to meet working capital needs.
Laidlaw & Company (UK) Ltd. acted as the sole placement agent with respect to the offering.
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for the treatment of cancer. The company develops therapies for life threatening diseases using its alpha particle immunotherapy platform and other related and similar technologies. Its products comprise Actimab-A, an antibody-drug construct, which comprises monoclonal antibody Lintuzumab and alpha emitting radioisotope actinium 225; and is in multicenter Phase I/II clinical trials for acute myeloid leukemia (AML).
At the end of Friday’s trade, Ingersoll-Rand PLC (NYSE:IR)‘s shares surged 0.09% to $69.11.
Ingersoll-Rand PLC (IR) a world leader in creating comfortable, sustainable and efficient environments, as vice president and chief accounting officer, effective right away. Kuehn will serve as the company’s principal accounting officer and be responsible for planned leadership and oversight of financial reporting, operational finance and technical accounting at Ingersoll Rand.
Kuehn joins Ingersoll Rand from Whirlpool Corporation where he served for three years as vice president, corporate controller and chief accounting officer. Prior to Whirlpool, Kuehn spent six years at SPX Corporation, most recently serving as chief financial officer for the thermal equipment and services segment of SPX. He was at PricewaterhouseCoopers for 12 years before SPX Corporation serving in financial leadership positions.
Kuehn will report to Carter as part of her leadership team and relocate to Davidson, N.C.
He holds an MBA from University of Rochester, a bachelor’s degree in accounting from State University of New York College at Geneseo. Kuehn is a certified public accountant.
Ingersoll-Rand plc, together with its auxiliaries, designs, manufactures, sells, and services a portfolio of industrial and commercial products. It operates through Climate and Industrial segments. The Climate segment offers heating, ventilation, and air conditioning (HVAC) systems, in addition to commercial and residential building services, parts, support, and controls under the Trane and American Standard brands; and transport temperature control solutions under the Thermo King brand.
Ally Financial Inc (NYSE:ALLY), ended its Friday’s trading session with 0.89% gain, and closed at $22.72.
Ally Financial Inc (ALLY) is officially rolling out its flagship vehicle service contract Ally Premier Protection to dealers nationwide starting this month. The product, which was previewed at the NADA convention in January, features improved benefits for auto consumers, powered by an intuitive and easy-to-use technology platform for dealers.
Dealers who take part in the pilot test were particularly impressed with the easy transition to Ally Premier Protection and the level of training they received from Ally. In a survey of pilot dealers, the vast majority (87 percent) of respondents said that the training they received during the transition to Ally Premier Protection was excellent, and 87 percent said that the overall transition was either “seamless” or “very smooth” with no or few unpredictable interruptions.
Ally Premier Protection is now accessible nationwide for nearly 650 makes and models of new and used vehicles and features new benefits counting expanded coverage eligibility on older and higher mileage vehicles, a disappearing deductible option, and full roadside assistance. On the back end, a cutting-edge technology platform called the Vehicle Protection Center makes the administration and administration of contracts easy and intuitive throughout the contract lifecycle and uses simplified processes to reduce errors and speed transactions. The system features claims integration with virtually every Dealer Administration System, and provides streamlined operations between Ally and dealer F&I and Service departments.
Ally Financial Inc. provides financial products and services primarily to automotive dealers and their customers in the United States. It offers dealer financial services, counting a range of financial services and insurance products to automotive dealers and retail customers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
